Pharmicell Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmicell Company Limited with three other
companies in this sector in KOREA (SOUTH) :
Eagle Veterinary Technology Co., Ltd
sales of 34.42 billion Korean Won [US$30.60 million]
HLB Pharmaceutical Co Ltd
(36.10 billion Korean Won [US$32.09 million]
of which 47%
was ETC), and
WooGene B&G CO., LTD
(33.62 billion Korean Won [US$29.89 million]
of which 100%
was microbial preparations).
During the year ended December of 2019, sales at
Pharmicell Company Limited were 32.48 billion Korean Won (US$28.88 million).
increase of 14.6%
versus 2018, when the company's sales were 28.35 billion Korean Won .
Sales of Chemical saw an increase
20.0% in 2019, from
23.25 billion Korean Won to 27.90 billion Korean Won .
Not all segments of Pharmicell Company Limited experienced an increase in sales in 2019:
sales of Bio-Business fell 10.2% to 4.58 billion Korean Won .